DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Rini BI, Escudier B, Tomczak P. et al.
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.
Lancet 2011;
378: 1931-1939
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.